RecallRadar

FDA Drug recall D-1144-2023

Milrinone Lactate Injection, USP 20mg/20 mL (1mg/mL), packaged in 10 x 20 mL vials per carton, NDC 72485-502-01 (single vial), Rx only, Dis…

On 2023-09-13 the FDA classified a Class III recall of Milrinone Lactate Injection, USP 20mg/20 mL (1mg/mL), packaged in 10 x 20 mL vials per carton, NDC 72485-502-01 (single vial), Rx only, Dis… by Caplin Steriles, citing failed Impurities/Degradation Specifications.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-1144-2023
ClassificationClass III
Statusterminated
Initiated2023-08-14
Published2023-09-13
Last updated2026-09-13 11:52 UTC
CompanyCaplin Steriles
DistributionUS

Product

Milrinone Lactate Injection, USP 20mg/20 mL (1mg/mL), packaged in 10 x 20 mL vials per carton, NDC 72485-502-01 (single vial), Rx only, Distributed by: Armas Pharmaceuticals, Inc. Freehold, NJ 07728(USA) Manufactured by: Caplin Steriles Limited, India, NDC 72485-502-10

Reason

Failed Impurities/Degradation Specifications

Identifiers

ndc72485-501-01
ndc72485-501-10
ndc72485-502-01
ndc72485-502-10
ndc72485-503-01
code_infoLot #: 90000228

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1144-2023%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.